Quantité totale PI	46
Rang # Quantité totale PI	30 043
Note d'activité PI	2,3/5.0    25
Rang # Activité PI	31 844
Classe Nice dominante	Services scientifiques, technolo...

Brevets Marques 18 6 3 0 17 0 2
Dernier brevet	2024 - Multispecific binding constructs...
Premier brevet	2016 - Multispecific immunomodulatory a...
Dernière marque	2020 - COMPASS THERAPEUTICS
Première marque	2015 - TARGETED IMMUNOMODULATION

Industrie (Classification de Nice)

Derniers inventions, produits et services 2024 Invention Multispecific binding constructs against checkpoint molecules and uses thereof. The present disc... 2023 Invention Agonist antibodies that bind human cd137 and uses thereof. The present disclosure relates to, in... Invention Cd137 antibodies and pd-1 antagonists and uses thereof. The present disclosure relates to combin... 2021 Invention Multispecific binding constructs against checkpoint molecules and uses thereof. The present discl... 2020 P/S Antibodies for scientific and research purposes Antibody therapeutic preparations for medical pur... P/S Scientific research in the field of biotechnology; medical and biomedical research P/S Antibodies for scientific and research purposes. Antibody therapeutic preparations for medical pu... Invention Agonist antibodies that bind human cd137 and uses thereof. The present disclosure relates to, int... Invention Common light chains and methods of use. The present disclosure provides methods of generating mul... Invention Formulations of antibodies that bind human cd137 and uses thereof. The present disclosure relate... Invention Formulations of antibodies that bind human cd137 and uses thereof. inter aliainter alia, stable f... Invention Formulations of antibodies that bind human cd137 and uses thereof. The present disclosure relates... 2019 Invention Transgenic mouse expressing common human light chain. The present disclosure relates to a transg... Invention Transgenic mouse expressing common human light chain. e.gKKK is expressed. Also provided are meth... Invention Multispecific binding constructs against checkpoint molecules and uses thereof. e.g.e.g., PD-1 an... Invention Antigen binding agents that bind cd277 and uses thereof. The present disclosure relates to, inte... Invention Antibodies that bind cd277 and uses thereof. The present disclosure relates to, inter alia, comp... Invention Antibodies that bind cd277 and uses thereof. inter aliae.g.e.g., antibodies, or antigen-binding f... Invention Antigen binding agents that bind cd277 and uses thereof. inter aliainter alia, methods for treati... Invention Antibodies that bind cd277 and uses thereof. The present disclosure relates to, inter alia, compo... Invention Agonist antibodies that bind human cd137 and uses thereof. The present disclosure relates to comp... Invention Compositions and methods for enhancing the killing of target cells by nk cells. The present disc... Invention Compositions and methods for enhancing the killing of target cells by nk cells. e.g.e.g., cancer ... Invention Multispecific antigen-binding compositions and methods of use. The present disclosure provides im... Invention Compositions and methods for enhancing the killing of target cells by nk cells. The present discl... Invention Agonist antibodies against human cd137 in cancer that express mhc i. The present disclosure relat... 2018 Invention Cd137 antibodies and tumor antigen-targeting antibodies and uses thereof. The present disclosure ... Invention Cd137 antibodies and pd-1 antagonists and uses thereof. The present disclosure relates to combina... Invention Filtration and chromatography pods and methods of using the same. Provided herein are methods of ... Invention Agonist antibodies that bind human cd137 and uses thereof. inter alia inter alia, compounds (e.g.... 2017 P/S Custom design and development of antigen-binding protein complexes for research and medical purposes Invention Multispecific immunomodulatory antigen-binding constructs. Provided herein are multispecific imm... Invention Multispecific immunomodulatory antigen-binding constructs. Provided herein are multispecific immu... 2016 Invention Compositions and methods for treating cancer via antagonism of the cd155/tigit pathway and tgf-be... Invention Compositions and methods for treating cancer via antagonism of the cd155/tigit pathway and tgf-.b... Invention Compositions and methods for treating cancer via antagonism of the cd155/tigit pathway and tgf-β.... 2015 P/S Antibodies for scientific and research purposes; chemical products and reagents for scientific pu...